Your verdict
Your page is mostly the same.
Most of what your page says, Bluesight says too. You're less same than 135 of the 366 SaaS sites scored (SaaS avg 56).
Each named site is scored the same way, against the other 3 in this set, so its tick means the same as your marker. The dashed line is the frozen benchmark average.
More same than average
The average SaaS site scores 56; you scored 60.
You are 4 points more same than the average SaaS site.
Closest overlap: Bluesight
Of the 3 sites you named, Bluesight echoes the most of what your page says. Scored the same way against the rest of the set, Bluesight sits at 60.
Bluesight is the competitor you sound most like.
Room to own more
27% of your claim space is ownable: unique, relevant, and hard to copy. 3 of those claims sit in body copy, where few readers reach them.
27% is ownable, and 3 buried opportunities could help you stand out more.
Three changes worth testing first.
Chosen by rule from the comparison with Bluesight, Terso Solutions and Marble: the shared claim taking your most prominent space, then the claims only you make that sit too low on the page to be read. Each one links to its claim card.
- “Know Exactly Where Every Critical, High-Value Medication is in Real Time”
Bluesight, Terso Solutions and Marble all say it too. Buyers may still need it, but shared ground cannot carry your hero — move it lower and give that space to something only you can say.
Table stakesMost of the set says this too. - “Temperature excursion, expiry, and recall alerts pushed to you”
Nobody in the set says this. It sits in body copy, where few readers reach it — worth testing higher up the page; only buyers can tell you whether it lands.
SurfaceYours alone. Test it higher up. - “Case-level accountability across anesthesiology, surgery, and nursing”
A claim that is yours alone, filed in body copy. Try it where it will be read before the shared claims are, and let buyers tell you if it moves them.
SurfaceYours alone. Test it higher up.
Try these changes, then test them with real buyers.
This measures overlap. Whether buyers notice is a different question, and only they can answer it.
What you can own
Claims only you make, that buyers weigh, and that competitors can’t easily copy.
27% of your page’s claim space is yours to keep.
Why this is not 100 minus the Sameness Index
The index is a weighted composite across six categories, including page structure and visuals. This bar is measured on your claims alone, weighted by where each one sits on the page. Different denominators, so the two never add to 100 and are not meant to.
Already leading with · 5
- Only/first connected RFID ecosystem for medications
“The only connected RFID ecosystem for medication inventory management”
- Modular expansion across the full workflow
“Plug-and-play expansion across central distribution, pharmacy, point of care, and enterprise intelligence”
- Quantified accuracy rate of ~99%
“99% medication identification accuracy”
- Single platform with one integration
“One platform architecture. One integration.”
- Tags and verifies inventory at receipt or prep
“Mira Prep tags and verifies inventory at the point of receipt or preparation”
Buried in body copy · 3
- Case- and clinician-level accountability per transaction
“Case-level accountability across anesthesiology, surgery, and nursing”
- Utilization data supports charge capture and 340B
“Precise utilization data for charge capture and 340B reconciliation”
- Automated temperature, expiry and recall alerts
“Temperature excursion, expiry, and recall alerts pushed to you”
Where you blend in
Territory you spend prominent space on that the set also occupies. Not every line is one to delete — the question is whether it has earned the space, or whether something only you can say should be there instead.
- Commodity · 100%Table stakesHeroreal-time item-level inventory visibility
- “Know Exactly Where Every Critical, High-Value Medication is in Real Time”
- “Enterprise-wide control”
You say this 2 different ways.
Bluesight, Terso Solutions and Marble all cover this territory. Buyers may need to hear it, but in your hero it spends the first impression on shared ground.
They say- Bluesight“integrating data from wholesalers, health records, dispensing cabinets, and HR systems”
- Terso Solutions“allowing you to gain control of high-value items across the supply chain”
- Marble“Real-time Tracking”
- Commodity · 67%KeepHerofirst or only connected RFID medication ecosystem
- “The only connected RFID ecosystem for medication inventory management”
Bluesight and Marble say what they are and who they are for, as every page in a category must. Keep it — it is orientation, not differentiation. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.
They say- Bluesight“We continuously innovate”
- Marble“We see a future where invisible technology guides and optimizes hospital supply chains”
- Commodity · 67%KeepHeropurpose-built for hospital pharmacy and healthcare
- “For Health Systems”
Bluesight and Terso Solutions say what they are and who they are for, as every page in a category must. Keep it — it is orientation, not differentiation.
They say- Bluesight“Purpose-built for hospital pharmacy and compliance workflows”
- Terso Solutions“When it comes to implementing RFID inventory management systems within the healthcare and life science industries, Terso Solutions is wholly dedicated to…”
- Commodity · 100%Table stakesSectionnamed customers and install base as proof
- “600+ Hospitals Served”
- “50M+ Medications Tracked”
You say this 2 different ways.
Common ground with Bluesight, Terso Solutions and Marble. Say it if buyers need it — lower on the page, where it is not the thing they read first.
They say- Bluesight“Trusted by [notable organizations]”
- Terso Solutions“With more than 3,500 RAIN RFID devices implemented worldwide since 2005”
- Marble“we've developed and launched products now utilized in over 1,000 hospitals”
- Commodity · 67%Table stakesSectionaccurate, trustworthy automated data capture
- “99% medication identification accuracy”
- “Upstream data integrity”
You say this 2 different ways.
Bluesight and Marble make the same claim (67% of the set). It cannot set you apart, so it should not carry the section. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.
They say- Bluesight“Automated inventory tracking you can trust”
- Marble“streamline inventory control”
- Commodity · 67%Table stakesSectionAI delivers predictive, actionable guidance
- “Mira Intelligence+ delivers predictive insights and translates them into daily, role-based actions”
A buyer comparing tabs sees this on Bluesight and Marble too (67% of the set). Yours earns nothing by repeating it up top; it can live lower down.
They say- Bluesight“Prism proactively monitors procurement, inventory, diversion, and privacy data”
- Marble“AI Optimization”
- Commodity · 67%Table stakesSectionimproves compliance, audit readiness and lowers risk
- “Stronger compliance and audit readiness”
Bluesight and Terso Solutions make the same claim (67% of the set). It cannot set you apart, so it should not carry the section.
They say- Bluesight“stronger compliance, smarter performance, and financial outcomes you can demonstrate to leadership”
- Terso Solutions“our inventory management systems allow you to automatically track and monitor inventory 24/7”
- Commodity · 67%Table stakesSectionintegrates via open standards without replacement
- “Open GS1 standards mean the ecosystem integrates with existing EHR, ERP, and medication systems, no rip-and-replace required”
Terso Solutions and Marble got here first as far as a buyer can tell. Keep the fact for readers who need it; move the position to a claim only your page can make.
They say- Terso Solutions“one that really stands out is our flexibility with integrating to your system”
- Marble“EHR Integration”
- Commodity · 67%Table stakesSectionone platform, one vendor, modular expansion
- “Plug-and-play expansion across central distribution, pharmacy, point of care, and enterprise intelligence”
- “One platform architecture. One integration.”
You say this 2 different ways.
Shared with Bluesight and Terso Solutions, 67% of the set. True of you, true of them — which is exactly why it will not decide anything. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.
They say- Bluesight“consolidate six essential solutions under one vendor”
- Terso Solutions“our RFID inventory management software solutions and our comprehensive services”
- Commodity · 67%Table stakesSectionreduces waste, cost and improves financial control
- “Better financial control”
- “Reduced waste and expiration loss”
You say this 2 different ways.
Shared with Bluesight and Marble, 67% of the set. True of you, true of them — which is exactly why it will not decide anything.
They say- Bluesight“Take control of drug spend across every order”
- Marble“reduce purchasing costs”
- Commodity · 67%Table stakesSectionsaves staff time on manual work
- “Less manual work, more clinical focus”
Nothing wrong with the claim; Bluesight and Marble just make it as well. Treat it as the price of entry and spend the prominent space elsewhere.
They say- Bluesight“No manual report-building”
- Marble“our solutions free up staff”
Claim-by-claim evidence
Every claim on your page (28)
What the columns mean
- Claim
- The grouped claim, then your exact line beneath it.
- Type
- What kind of claim it is: category, segment, outcome, capability, quality or proof.
- Placement
- Where it sits on your page: hero, section or body copy. Hero claims weigh most in the index.
- Same claim
- Share of the competitors making this exact claim. Drives ownership and ownable share.
- Same territory
- Share of the competitors with any claim in the same buyer-facing territory. This is what the index is scored on.
- Sayability
- Whether a competitor could truthfully make the same claim: anyone could, copyable with effort, or hard to copy.
- Relevant
- Whether buyers decide on this. A unique claim nobody buys on is not ownable.
- Ownership
- Commodity: 60% or more of the set says it. Contested: 20–59%. Unique: under 20%, owned when it is also hard to copy.
Tap a column to sort by it; tap again to reverse. Sorted by Same claim, highest first.
Unified view integrating RFID, EHR, ADC and other systems “One unified view across RFID, EHR, ADCs, and other systems” | capability | Body | 100% | 100% | Copyable with effort | Yes | Commodity |
Built for health systems / hospital pharmacy “For Health Systems” | segment | Hero | 67% | 67% | Anyone could say it | Yes | Commodity |
AI turns data into predictive, role-based actions “Mira Intelligence+ delivers predictive insights and translates them into daily, role-based actions” | capability | Section | 67% | 67% | Anyone could say it | Yes | Commodity |
Better financial control / lower costs “Better financial control” | outcome | Section | 67% | 67% | Anyone could say it | Yes | Commodity |
Installed at hundreds/thousands of hospitals “600+ Hospitals Served” | proof | Section | 67% | 100% | Copyable with effort | Yes | Commodity |
Less manual work frees staff time “Less manual work, more clinical focus” | outcome | Section | 67% | 67% | Anyone could say it | Yes | Commodity |
Open standards integration without rip-and-replace “Open GS1 standards mean the ecosystem integrates with existing EHR, ERP, and medication systems, no rip-and-replace required” | capability | Section | 67% | 67% | Copyable with effort | Yes | Commodity |
Trusted by leading healthcare organizationsgrouping uncertain “Trusted by Leading Health Systems” | proof | Section | 67% | 100% | Anyone could say it | Yes | Commodity |
Real-time item-level visibility into every medication “Know Exactly Where Every Critical, High-Value Medication is in Real Time” | outcome | Hero | 33% | 100% | Copyable with effort | Yes | Contested |
Enterprise-wide control of high-value inventory “Enterprise-wide control” | outcome | Section | 33% | 100% | Anyone could say it | Yes | Contested |
Fast secure medication access without workflow disruptiongrouping uncertain “Mira Care Workstation offers fast, secure medication access in the OR without disrupting clinical workflows” | quality | Section | 33% | 67% | Anyone could say it | Yes | Contested |
Improves compliance and audit readiness “Stronger compliance and audit readiness” | outcome | Section | 33% | 67% | Anyone could say it | Yes | Contested |
Detects or deters drug diversion “A visible chain of custody to help prevent diversion” | outcome | Body | 33% | 67% | Copyable with effort | Yes | Contested |
Every transaction documented automatically “Every transaction is documented automatically” | capability | Body | 33% | 67% | Copyable with effort | Yes | Contested |
Only/first connected RFID ecosystem for medications “The only connected RFID ecosystem for medication inventory management” | category | Hero | 0% | 67% | Copyable with effort | Yes | Unique and owned |
Accurate data captured at the source “Upstream data integrity” | quality | Section | 0% | 67% | Anyone could say it | Yes | Unique for now |
Modular expansion across the full workflow “Plug-and-play expansion across central distribution, pharmacy, point of care, and enterprise intelligence” | capability | Section | 0% | 67% | Copyable with effort | Yes | Unique and owned |
Quantified accuracy rate of ~99% “99% medication identification accuracy” | proof | Section | 0% | 67% | Copyable with effort | Yes | Unique and owned |
Reduces drug waste and expiration loss “Reduced waste and expiration loss” | outcome | Section | 0% | 67% | Anyone could say it | Yes | Unique for now |
Self-serve ROI calculator in 60 seconds “See your facility's Mira savings in 60 seconds” | outcome | Section | 0% | 0% | Anyone could say it | No | Unique for now |
Single platform with one integration “One platform architecture. One integration.” | capability | Section | 0% | 67% | Copyable with effort | Yes | Unique and owned |
Tags and verifies inventory at receipt or prep “Mira Prep tags and verifies inventory at the point of receipt or preparation” | capability | Section | 0% | 0% | Copyable with effort | Yes | Unique and owned |
Volume of medications tracked to date “50M+ Medications Tracked” | proof | Section | 0% | 100% | Copyable with effort | No | Unique and owned |
Automated temperature, expiry and recall alerts “Temperature excursion, expiry, and recall alerts pushed to you” | capability | Body | 0% | 0% | Copyable with effort | Yes | Unique and owned |
Case- and clinician-level accountability per transaction “Case-level accountability across anesthesiology, surgery, and nursing” | capability | Body | 0% | 67% | Copyable with effort | Yes | Unique and owned |
Holds RFID patents “RFID Patents” | proof | Body | 0% | 0% | Hard to copy | No | Unique and owned |
Models multi-year savings including 340B revenue “Model annual and 5-year savings across drug waste, charge capture, and 340B revenue” | capability | Body | 0% | 67% | Copyable with effort | No | Unique and owned |
Utilization data supports charge capture and 340B “Precise utilization data for charge capture and 340B reconciliation” | capability | Body | 0% | 67% | Copyable with effort | Yes | Unique and owned |
- Unified view integrating RFID, EHR, ADC and other systems“One unified view across RFID, EHR, ADCs, and other systems”capabilityBodysame claim 100%same territory 100%Copyable with effortCommodityAlso on Bluesight, Terso Solutions, Marble
- Built for health systems / hospital pharmacy“For Health Systems”segmentHerosame claim 67%same territory 67%Anyone could say itCommodityAlso on Bluesight, Terso Solutions
- AI turns data into predictive, role-based actions“Mira Intelligence+ delivers predictive insights and translates them into daily, role-based actions”capabilitySectionsame claim 67%same territory 67%Anyone could say itCommodityAlso on Bluesight, Marble
- Better financial control / lower costs“Better financial control”outcomeSectionsame claim 67%same territory 67%Anyone could say itCommodityAlso on Bluesight, Marble
- Installed at hundreds/thousands of hospitals“600+ Hospitals Served”proofSectionsame claim 67%same territory 100%Copyable with effortCommodityAlso on Terso Solutions, Marble
- Less manual work frees staff time“Less manual work, more clinical focus”outcomeSectionsame claim 67%same territory 67%Anyone could say itCommodityAlso on Bluesight, Marble
- Open standards integration without rip-and-replace“Open GS1 standards mean the ecosystem integrates with existing EHR, ERP, and medication systems, no rip-and-replace required”capabilitySectionsame claim 67%same territory 67%Copyable with effortCommodityAlso on Terso Solutions, Marble
- Trusted by leading healthcare organizationsgrouping uncertain“Trusted by Leading Health Systems”proofSectionsame claim 67%same territory 100%Anyone could say itCommodityAlso on Bluesight, Marble
- Real-time item-level visibility into every medication“Know Exactly Where Every Critical, High-Value Medication is in Real Time”outcomeHerosame claim 33%same territory 100%Copyable with effortContestedAlso on Marble
- Enterprise-wide control of high-value inventory“Enterprise-wide control”outcomeSectionsame claim 33%same territory 100%Anyone could say itContestedAlso on Terso Solutions
- Fast secure medication access without workflow disruptiongrouping uncertain“Mira Care Workstation offers fast, secure medication access in the OR without disrupting clinical workflows”qualitySectionsame claim 33%same territory 67%Anyone could say itContestedAlso on Marble
- Improves compliance and audit readiness“Stronger compliance and audit readiness”outcomeSectionsame claim 33%same territory 67%Anyone could say itContestedAlso on Bluesight
- Detects or deters drug diversion“A visible chain of custody to help prevent diversion”outcomeBodysame claim 33%same territory 67%Copyable with effortContestedAlso on Bluesight
- Every transaction documented automatically“Every transaction is documented automatically”capabilityBodysame claim 33%same territory 67%Copyable with effortContestedAlso on Terso Solutions
- Only/first connected RFID ecosystem for medications“The only connected RFID ecosystem for medication inventory management”categoryHerosame claim 0%same territory 67%Copyable with effortUnique and owned
- Accurate data captured at the source“Upstream data integrity”qualitySectionsame claim 0%same territory 67%Anyone could say itUnique for now
- Modular expansion across the full workflow“Plug-and-play expansion across central distribution, pharmacy, point of care, and enterprise intelligence”capabilitySectionsame claim 0%same territory 67%Copyable with effortUnique and owned
- Quantified accuracy rate of ~99%“99% medication identification accuracy”proofSectionsame claim 0%same territory 67%Copyable with effortUnique and owned
- Reduces drug waste and expiration loss“Reduced waste and expiration loss”outcomeSectionsame claim 0%same territory 67%Anyone could say itUnique for now
- Self-serve ROI calculator in 60 seconds“See your facility's Mira savings in 60 seconds”outcomeSectionsame claim 0%same territory 0%Anyone could say itnot a buying criterionUnique for now
- Single platform with one integration“One platform architecture. One integration.”capabilitySectionsame claim 0%same territory 67%Copyable with effortUnique and owned
- Tags and verifies inventory at receipt or prep“Mira Prep tags and verifies inventory at the point of receipt or preparation”capabilitySectionsame claim 0%same territory 0%Copyable with effortUnique and owned
- Volume of medications tracked to date“50M+ Medications Tracked”proofSectionsame claim 0%same territory 100%Copyable with effortnot a buying criterionUnique and owned
- Automated temperature, expiry and recall alerts“Temperature excursion, expiry, and recall alerts pushed to you”capabilityBodysame claim 0%same territory 0%Copyable with effortUnique and owned
- Case- and clinician-level accountability per transaction“Case-level accountability across anesthesiology, surgery, and nursing”capabilityBodysame claim 0%same territory 67%Copyable with effortUnique and owned
- Holds RFID patents“RFID Patents”proofBodysame claim 0%same territory 0%Hard to copynot a buying criterionUnique and owned
- Models multi-year savings including 340B revenue“Model annual and 5-year savings across drug waste, charge capture, and 340B revenue”capabilityBodysame claim 0%same territory 67%Copyable with effortnot a buying criterionUnique and owned
- Utilization data supports charge capture and 340B“Precise utilization data for charge capture and 340B reconciliation”capabilityBodysame claim 0%same territory 67%Copyable with effortUnique and owned
How this was calculated
Sameness measures how much your claims overlap with the sites compared. It does not measure message quality or whether buyers prefer you.
AI-analyzed: an AI read each page on its own and grouped the claims that say the same thing. No score here was written by a model — every number is computed from those groupings in our own code, with the weights below.
How the score is built
| Category | Weight | Yours | What a high score means |
|---|---|---|---|
Messaging Category framing, who it is for, and the outcome promised | 30% | 69 | The most expensive kind of sameness. A buyer cannot tell what job you do that the others do not. |
Claims Attribute and benefit claims — speed, ease, quality, ROI | 30% | 67 | Every shared claim is a line already read on another tab. Cut the ones nobody owns and spend the space on something they cannot. |
Features Capabilities and functions the page lists | 15% | 56 | Expected in a mature category, and the least alarming of the six. Feature parity is normal; leading with it is the mistake. |
Proof The kinds of evidence offered: customer logos, numbers, testimonials, case studies, badges | 10% | 27 | Same kinds of proof as everyone means the proof stops working as proof. It is scored on the kind of evidence, not on which customers are named. |
Structure Section order, navigation, CTA language and placement | 10% | 51 | The generic SaaS template — hero, logos, three-feature grid, testimonial, CTA. Familiar is not the same as memorable. |
Visual Palette family, imagery style, layout patterns | 5% | 56 | Weighted lowest on purpose: buyers rarely decide on this. Worth knowing, rarely worth fixing first. |
Each site was read on its own first, with no knowledge of the others, so your page gets no benefit of the doubt a competitor’s does not. A category nothing could be measured for drops out and the rest are re-weighted, rather than counted as zero.
What we compared (4 pages read)
What it cannot tell you
The index can find where two pages converge. It cannot say whether a buyer would notice, or which of your reasons to buy actually land. A single check also moves several points between runs, so read the band and the ranking, not the last digit.
Your highest-impact changes
- 1Table stakesYour hero copy says “Know Exactly Where Every Critical, High-Value Medication is in Real Time”.
Bluesight, Terso Solutions and Marble all say it too. Buyers may still need it, but shared ground cannot carry your hero — move it lower and give that space to something only you can say.
- 2Table stakesYour hero copy says “For Health Systems”.
Keep the fact, lose the position: bluesight and Terso Solutions say it too (67% of the set), and your hero is spending its first impression on the same territory as theirs.
- 3Table stakesYour section copy says “Enterprise-wide control”.
This is the set's common ground — Bluesight, Terso Solutions and Marble all say it too. It will not set you apart wherever it sits, and in the section it costs you the one place a distinctive claim would be read.
- 4Table stakesYour section copy says “600+ Hospitals Served”.
A buyer with three tabs open reads a version of this on every one of them. Say it further down for the readers who need it; the section should carry a claim they will only find here.
- 5Table stakesYour section copy says “50M+ Medications Tracked”.
True of you and true of them: Bluesight, Terso Solutions and Marble all say it too. That is why it decides nothing, and why the section is the wrong place to spend it.
- 6Table stakesYour section copy says “Mira Intelligence+ delivers predictive insights and translates them into daily, role-based actions”.
In the section: Bluesight and Marble say it too (67% of the set). Buyers may still need it, but shared ground cannot carry your section — move it lower and give that space to something only you can say.
- 7Table stakesYour section copy says “Better financial control”.
In the section: Keep the fact, lose the position: bluesight and Marble say it too (67% of the set), and your section is spending its first impression on the same territory as theirs.
- 8Table stakesYour section copy says “Less manual work, more clinical focus”.
In the section: True of you and true of them: Bluesight and Marble say it too (67% of the set). That is why it decides nothing, and why the section is the wrong place to spend it.
- 9Surface“Temperature excursion, expiry, and recall alerts pushed to you” is yours alone, and buyers weigh it.
Nobody in the set says this. It sits in body copy, where few readers reach it — worth testing higher up the page; only buyers can tell you whether it lands.
- 10Surface“Case-level accountability across anesthesiology, surgery, and nursing” is yours alone, and buyers weigh it.
A claim that is yours alone, filed in body copy. Try it where it will be read before the shared claims are, and let buyers tell you if it moves them.
- 11Surface“Precise utilization data for charge capture and 340B reconciliation” is yours alone, and buyers weigh it.
No competitor page makes this claim. Today it is in body copy; it is a candidate for the space the table-stakes lines are taking.
The only way to know if it matters.
This report can tell you where your messaging overlaps. It cannot tell you whether a buyer would care, or which of your reasons to buy actually land. Put the page in front of real B2B buyers in your target market and ask them.







